Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neramexane in Subjective Tinnitus (OLLTT)
NCT00827008Phase 3Terminated
- Sponsor
- Merz
- Start
- Jan 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of neramexane in tinnitus, sponsored by Merz. Started Jan 2009; status: terminated.
02
Drugs
neramexane
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT00827008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827008.